glp-1 reimbursement news Pfizer, Innovent drugs clear China insurance hurdle Fmr. FDA Commissioner weighs in

First Mover States in GLP-1 Coverage Colorado No state garnered more attention than Colorado

However, real-world experience and the pharmacokinetic principles of volume of distribution suggest that lighter individuals benefit from a more conservative start, while heavier individuals may tolerate a slightly more aggressive approach

Room-temperature medication causes significantly less stinging than cold medication

Reduced estrogen also causes a fat redistribution to the abdomen in the form of visceral fat, which is linked to increased risk of insulin resistance and other metabolic diseases

How GLP-1s cause weight loss may further complicate whether they can be considered performance-enhancing

Ozempic and Zepbound branded options are listed at $1,299/month and $1,399/month respectively - substantially higher, which reflects the cost of FDA-approved branded medications versus compounded alternatives